Cargando…

Rheumatoid arthritis–associated autoantibodies in non–rheumatoid arthritis patients with mucosal inflammation: a case–control study

INTRODUCTION: Rheumatoid arthritis–associated autoantibodies (RA-AAB) can be present in serum years before clinical onset of rheumatoid arthritis (RA). It has been hypothesized that initiation of RA-AAB generation occurs at inflamed mucosal surfaces, such as in the oral cavity or lungs. The aim of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Janssen, Koen M J, de Smit, Menke J, Brouwer, Elisabeth, de Kok, Fenne A C, Kraan, Jan, Altenburg, Josje, Verheul, Marije K, Trouw, Leendert A, van Winkelhoff, Arie Jan, Vissink, Arjan, Westra, Johanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496865/
https://www.ncbi.nlm.nih.gov/pubmed/26155788
http://dx.doi.org/10.1186/s13075-015-0690-6
_version_ 1782380473860751360
author Janssen, Koen M J
de Smit, Menke J
Brouwer, Elisabeth
de Kok, Fenne A C
Kraan, Jan
Altenburg, Josje
Verheul, Marije K
Trouw, Leendert A
van Winkelhoff, Arie Jan
Vissink, Arjan
Westra, Johanna
author_facet Janssen, Koen M J
de Smit, Menke J
Brouwer, Elisabeth
de Kok, Fenne A C
Kraan, Jan
Altenburg, Josje
Verheul, Marije K
Trouw, Leendert A
van Winkelhoff, Arie Jan
Vissink, Arjan
Westra, Johanna
author_sort Janssen, Koen M J
collection PubMed
description INTRODUCTION: Rheumatoid arthritis–associated autoantibodies (RA-AAB) can be present in serum years before clinical onset of rheumatoid arthritis (RA). It has been hypothesized that initiation of RA-AAB generation occurs at inflamed mucosal surfaces, such as in the oral cavity or lungs. The aim of this study was to assess systemic presence of RA-AAB in patients without RA who had oral or lung mucosal inflammation. METHODS: The presence of RA-AAB (immunoglobulin A [IgA] and IgG anti-cyclic citrullinated peptide 2 antibodies (anti-CCP2), IgM and IgA rheumatoid factor (RF), IgG anti-carbamylated protein antibodies and IgG and IgA anti-citrullinated peptide antibodies against fibrinogen, vimentin and enolase) were determined in sera of non-RA patients with periodontitis (PD, n = 114), bronchiectasis (BR, n = 80) or cystic fibrosis (CF, n = 41). Serum RA-AAB levels were compared with those of periodontally healthy controls (n = 36). Patients with established RA (n = 86) served as a reference group. Association of the diseases with RA-AAB seropositivity was assessed with a logistic regression model, adjusted for age, sex and smoking. RESULTS: Logistic regression analysis revealed that IgG anti-CCP seropositivity was associated with BR and RA, whereas the association with PD was borderline significant. IgA anti-CCP seropositivity was associated with CF and RA. IgM RF seropositivity was associated with RA, whereas the association with BR was borderline significant. IgA RF seropositivity was associated with CF and RA. Apart from an influence of smoking on IgA RF in patients with RA, there was no influence of age, sex or smoking on the association of RA-AAB seropositivity with the diseases. Anti-CarP levels were increased only in patients with RA. The same held for IgG reactivity against all investigated citrullinated peptides. CONCLUSION: Although overall levels were low, RA-AAB seropositivity was associated with lung mucosal inflammation (BR and CF) and may be associated with oral mucosal inflammation (PD). To further determine whether mucosal inflammation functions as a site for induction of RA-AAB and precedes RA, longitudinal studies are necessary in which RA-AAB of specifically the IgA isotype should be assessed in inflamed mucosal tissues and/or in their inflammatory exudates.
format Online
Article
Text
id pubmed-4496865
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44968652015-07-10 Rheumatoid arthritis–associated autoantibodies in non–rheumatoid arthritis patients with mucosal inflammation: a case–control study Janssen, Koen M J de Smit, Menke J Brouwer, Elisabeth de Kok, Fenne A C Kraan, Jan Altenburg, Josje Verheul, Marije K Trouw, Leendert A van Winkelhoff, Arie Jan Vissink, Arjan Westra, Johanna Arthritis Res Ther Research Article INTRODUCTION: Rheumatoid arthritis–associated autoantibodies (RA-AAB) can be present in serum years before clinical onset of rheumatoid arthritis (RA). It has been hypothesized that initiation of RA-AAB generation occurs at inflamed mucosal surfaces, such as in the oral cavity or lungs. The aim of this study was to assess systemic presence of RA-AAB in patients without RA who had oral or lung mucosal inflammation. METHODS: The presence of RA-AAB (immunoglobulin A [IgA] and IgG anti-cyclic citrullinated peptide 2 antibodies (anti-CCP2), IgM and IgA rheumatoid factor (RF), IgG anti-carbamylated protein antibodies and IgG and IgA anti-citrullinated peptide antibodies against fibrinogen, vimentin and enolase) were determined in sera of non-RA patients with periodontitis (PD, n = 114), bronchiectasis (BR, n = 80) or cystic fibrosis (CF, n = 41). Serum RA-AAB levels were compared with those of periodontally healthy controls (n = 36). Patients with established RA (n = 86) served as a reference group. Association of the diseases with RA-AAB seropositivity was assessed with a logistic regression model, adjusted for age, sex and smoking. RESULTS: Logistic regression analysis revealed that IgG anti-CCP seropositivity was associated with BR and RA, whereas the association with PD was borderline significant. IgA anti-CCP seropositivity was associated with CF and RA. IgM RF seropositivity was associated with RA, whereas the association with BR was borderline significant. IgA RF seropositivity was associated with CF and RA. Apart from an influence of smoking on IgA RF in patients with RA, there was no influence of age, sex or smoking on the association of RA-AAB seropositivity with the diseases. Anti-CarP levels were increased only in patients with RA. The same held for IgG reactivity against all investigated citrullinated peptides. CONCLUSION: Although overall levels were low, RA-AAB seropositivity was associated with lung mucosal inflammation (BR and CF) and may be associated with oral mucosal inflammation (PD). To further determine whether mucosal inflammation functions as a site for induction of RA-AAB and precedes RA, longitudinal studies are necessary in which RA-AAB of specifically the IgA isotype should be assessed in inflamed mucosal tissues and/or in their inflammatory exudates. BioMed Central 2015-07-09 2015 /pmc/articles/PMC4496865/ /pubmed/26155788 http://dx.doi.org/10.1186/s13075-015-0690-6 Text en © Janssen et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise credited.
spellingShingle Research Article
Janssen, Koen M J
de Smit, Menke J
Brouwer, Elisabeth
de Kok, Fenne A C
Kraan, Jan
Altenburg, Josje
Verheul, Marije K
Trouw, Leendert A
van Winkelhoff, Arie Jan
Vissink, Arjan
Westra, Johanna
Rheumatoid arthritis–associated autoantibodies in non–rheumatoid arthritis patients with mucosal inflammation: a case–control study
title Rheumatoid arthritis–associated autoantibodies in non–rheumatoid arthritis patients with mucosal inflammation: a case–control study
title_full Rheumatoid arthritis–associated autoantibodies in non–rheumatoid arthritis patients with mucosal inflammation: a case–control study
title_fullStr Rheumatoid arthritis–associated autoantibodies in non–rheumatoid arthritis patients with mucosal inflammation: a case–control study
title_full_unstemmed Rheumatoid arthritis–associated autoantibodies in non–rheumatoid arthritis patients with mucosal inflammation: a case–control study
title_short Rheumatoid arthritis–associated autoantibodies in non–rheumatoid arthritis patients with mucosal inflammation: a case–control study
title_sort rheumatoid arthritis–associated autoantibodies in non–rheumatoid arthritis patients with mucosal inflammation: a case–control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496865/
https://www.ncbi.nlm.nih.gov/pubmed/26155788
http://dx.doi.org/10.1186/s13075-015-0690-6
work_keys_str_mv AT janssenkoenmj rheumatoidarthritisassociatedautoantibodiesinnonrheumatoidarthritispatientswithmucosalinflammationacasecontrolstudy
AT desmitmenkej rheumatoidarthritisassociatedautoantibodiesinnonrheumatoidarthritispatientswithmucosalinflammationacasecontrolstudy
AT brouwerelisabeth rheumatoidarthritisassociatedautoantibodiesinnonrheumatoidarthritispatientswithmucosalinflammationacasecontrolstudy
AT dekokfenneac rheumatoidarthritisassociatedautoantibodiesinnonrheumatoidarthritispatientswithmucosalinflammationacasecontrolstudy
AT kraanjan rheumatoidarthritisassociatedautoantibodiesinnonrheumatoidarthritispatientswithmucosalinflammationacasecontrolstudy
AT altenburgjosje rheumatoidarthritisassociatedautoantibodiesinnonrheumatoidarthritispatientswithmucosalinflammationacasecontrolstudy
AT verheulmarijek rheumatoidarthritisassociatedautoantibodiesinnonrheumatoidarthritispatientswithmucosalinflammationacasecontrolstudy
AT trouwleenderta rheumatoidarthritisassociatedautoantibodiesinnonrheumatoidarthritispatientswithmucosalinflammationacasecontrolstudy
AT vanwinkelhoffariejan rheumatoidarthritisassociatedautoantibodiesinnonrheumatoidarthritispatientswithmucosalinflammationacasecontrolstudy
AT vissinkarjan rheumatoidarthritisassociatedautoantibodiesinnonrheumatoidarthritispatientswithmucosalinflammationacasecontrolstudy
AT westrajohanna rheumatoidarthritisassociatedautoantibodiesinnonrheumatoidarthritispatientswithmucosalinflammationacasecontrolstudy